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Abstract
About one-fourth of ischemic strokes occur in working-aged individuals in the high-income countries, with worldwide
increasing incidence in this age group from 1980s to present. Recent evidence suggests that traditional vascular risk
factors are more prevalent than previously suggested in young adult stroke patients and they accumulate with age
particularly in men. Accordingly, relatively high rates of atherosclerotic changes have been detected in these patients.
The strength of association of vascular risk factors has gone poorly studied, however. Many young patients with ischemic
stroke have, in turn, no traditional risk factors, while they may harbor other conditions with weak or uncertain asso-
ciation with the stroke alone. These individual conditions often represent a risk factor that may be strictly young-age
specific, more prevalent in younger than older stroke patients (e.g. patent foramen ovale), or more prevalent among the
young in the population. Despite high rates of vascular risk factors and atherosclerotic changes, these findings do not
translate to higher frequencies of identified classical stroke mechanisms. In fact, cryptogenic causes are markedly
common and even more frequent among the very young patients. Limited randomized trial evidence exists to support
secondary prevention decision-making in patients, yet they face an increased risk of death and future vascular events for
years to come—dependent on risk factor profile and cause of the stroke. This review provides an overview of recent
data on epidemiology, risk factors, and their strength of association in ischemic stroke in the young. Furthermore, the
relationship between with the risk factors and cardiovascular outcomes and key features on the evidence related to
secondary prevention will be discussed.
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Introduction
Ischemic stroke is no longer a disease aﬀecting just eld-
erly people, since one-fourth of ischemic strokes occur
in working-aged individuals in the high-income coun-
tries, new stroke striking an estimated 3.6 million young
people each year. The burden of young stroke may be
increasing further, since multiple recent studies have
reported increasing incidence of ischemic strokes par-
ticularly at younger ages since 1980s, while incidence at
older ages has been declining during the same period.1–5
Globally almost half of the entire stroke burden now
aﬀects young individuals given that they have a greater
likelihood to survive their strokes with long life spans
ahead and because strokes occur at younger ages in
low- and middle-income countries.6 Moreover, the
overall population burden of cerebrovascular disease
in the young may be underestimated, since clinically
silent infarcts and white-matter changes have been
shown to be prevalent even in young stroke patients.7,8
Approximately 10% of ischemic strokes occur in
people aged less than 50 years, which is the age cut oﬀ
most often used to deﬁne ‘‘early onset’’ or ‘‘young-onset
stroke’’ or ‘‘stroke in young adults.’’9,10 The age cut oﬀ is
biologically arbitrary but is based on the diﬀering clinical
characteristics between younger and older stroke
patients, in particular risk factors and etiology.11
Recent evidence suggests that traditional vascular
risk factors are highly prevalent in young adult stroke
populations with distinct demographic characteris-
tics,12,13 yet the strength of association of these risk
factors has received scarce attention. On the contrary,
Department of Neurology, Helsinki University Hospital, Helsinki, Finland
Corresponding author:
Jukka Putaala, Department of Neurology, Helsinki University Hospital,
Haartmaninkatu 4, FI-00029 Helsinki, Finland.
Email: jukka.putaala@hus.fi
European Stroke Journal
2016, Vol. 1(1) 28–40
! European Stroke Organisation
2016
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/2396987316629860
eso.sagepub.com
there are also young patients without traditional risk
factors, while these individuals may harbor other con-
ditions with only weak or uncertain association with
the stroke alone. These conditions often represent a
risk factor that may be strictly young-age speciﬁc,
more prevalent in younger than older patients, or
more prevalent among young people in the population.
Although vascular risk factors among young stroke
patients may be more common than previously sug-
gested and relatively high rates of atherosclerotic
changes have been detected, these ﬁndings do not trans-
late to higher frequencies of identiﬁed classical stroke
mechanisms.14,15 In fact, undetermined (or cryptogenic
or hidden) causes are exceedingly common and even
more frequent the younger the patients, the proportion
exceeding 50% in patients younger than 30 years.16,17
This review ﬁrst provides an overview of recent epi-
demiological ﬁndings on ischemic stroke in the young.
Second, the current knowledge on the prevalence of
modiﬁable traditional vascular as well as unconven-
tional risk factors and their strength of association
with early onset stroke will be discussed. The last part
of the review will cover the relationship between with
the risk factors and cardiovascular outcomes as well as
key aspects on the evidence of secondary prevention in
this patient population.
Literature search
References for this review were identiﬁed through
searches of PubMed with the MeSH search terms
‘‘Stroke’’ and (‘‘Young Adult’’ or ‘‘Adult,’’ or
‘‘Middle Aged’’). Further search restrictions were
done based on the review topics, including terms
‘‘Incidence,’’ ‘‘Risk Factors,’’ (‘‘Etiology’’ or
‘‘Pathogenesis’’), ‘‘Patent Foramen Ovale,’’ (PFO)
and ‘‘Prognosis.’’ Relevant papers were also identiﬁed
through searches of author’s ﬁles and by review of ref-
erence lists of the relevant articles. Congress abstracts
were excluded and only full-text articles published in
English were considered.
Incidence of ischemic stroke
at younger ages
Relatively few studies have assessed the incidence of
ischemic stroke in the young, it is important to bear
in the mind the varying upper age cut oﬀ and popula-
tion when comparing the rates. From the last three dec-
ades the reported rates for individuals aged 15–45 vary
from 3.4 to 21.7 per 100,000,18–23 the highest rate
observed for Blacks in the Baltimore–Washington
area.20 For those aged 15–49, incidence ranges from
10.8 to 11.4 per 100,000 in people of Northern
European origin.9,24
Incidence remains low among the youngest individ-
uals, ranging from 1.2 to 4.5 per 100,000 in those aged
<35 years, but then steeply increases with age, reaching
32.9 per 100,000 among those aged 45–49 years
(Figure 1).9 Generally in the young incidence for men is
higher except for a few studies reporting higher incidence
for women.23,25 There are notable gender diﬀerences in
Figure 1. Occurrence rates of ischemic stroke according to age and sex among individuals aged 15–49 years. Data are from the
Helsinki Young Stroke Registry including 1008 consecutive patients with first-ever ischemic stroke.9
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theoccurrenceofearlyonsetstroke,aswomenoutnumber
men among those aged<35 years, whereasmen outnum-
ber women among those aged above 35 but less than 50
years (Figure 2).13The reasons for these sexdiscrepancies
probably includegender-speciﬁc risk factors in reproduc-
tively active young women and clustering of traditional
risk factors in middle-aged men, as discussed below.
A number of recent epidemiological studies remark-
ably show that incidence of ischemic stroke at younger
ages has been increasing since 1980s to present.1–5 Some
of the studies showedmorepronounced incidence increase
in women,1,4 which challenges the current epidemiologic
view of male preponderance in ischemic stroke.26
Possible explanations for the increasing incidence
include (1) artiﬁcial, i.e. improved awareness in the
population or improved diagnostic accuracy; (2) grow-
ing prevalence of known stroke risk factors, e.g. increas-
ing prevalence physical inactivity, obesity, type 2
diabetes mellitus, increasing use of alcohol and illicit
drugs; (3) increasing prevalence of factors related to
modern life style with limited scientiﬁc evidence and
uncertain causality, e.g. 24/7 society syndrome including
long work hours, shift work, long-haul ﬂights, informa-
tion overload, chronic stress, sleep deprivation; or (4)
external reasons, such as increasing exposure to particu-
late matters in the air.
Figure 2. Prevalence of traditional vascular risk factors in young adults with ischemic stroke according to sex and age group.
Adapted from von Sarnowski et al.12
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Only scarce systematic data are available thus far
regarding the reasons for the increasing incidence of
early onset stroke. Kissela and coworkers demonstrated
a growing use of MRI in stroke diagnostics from early
1990s to 2005 correlating to improving diagnostic
accuracy, but similar change in MRI use was seen
across all age groups and with even greater magnitude
for those aged 65 years.3 National surveys suggest an
increase in the population prevalence of obesity, hyper-
cholesterolemia, and diabetes (www.cdc.gov/nchs/
nhanes) and in young stroke patients smoking, alcohol
drinking, and illicit drug use have been increasing
during the same period as the observed increase of inci-
dence.27 Probably some of the increment might be
explained by improved diagnostics and disease aware-
ness, but the strong risk factors becoming more preva-
lent appear among the most robust potential
explanations underlying the increasing incidence at
younger ages.
Prevalence of traditional modifiable
risk factors in young patients
The Stroke in Young Fabry Patients (SIFAP1) study
was a prospective European multicenter study, which
primary aim was to decipher the prevalence of Fabry
disease in unselected 5024 young (age 18–55 years)
stroke patients, recruited from 2007 to 2010. While
deﬁnitive Fabry disease was diagnosed in 0.5% of the
entire cohort,16 the database also provided—for the
ﬁrst time in this scale—systematic information on the
prevalence of well-documented vascular risk factors in
young stroke patients. The four most frequent risk fac-
tors were current smoking (56%), physical inactivity
(48%), hypertension (47%), and dyslipidemia (35%).
One out of 10 had diabetes mellitus.12
Obesity deﬁned as body mass index (BMI) 30
emerged in 22% of the SIFAP1 study patients, yet if
deﬁned with waist circumference (94 cm for men,
80 cm for women), abdominal obesity was in fact
the most prevalent risk factor in the cohort (i.e.
69%).12 BMI 30 has been shown to be more prevalent
among younger individuals in the population28 and this
measure of obesity has recently been associated with
young-onset stroke in a case–control study.29
However, the risk eﬀect of BMI 30 may be mediated
through associated conditions such as hypertension and
diabetes mellitus since the association was greatly atte-
nuated after adjusting for these factors.29 Compared to
BMI, anthropometric measures of abdominal fat
including waist circumference, waist-to-hip ratio, and
waist-to-stature ratio may, however, more accurately
predict stroke risk and independent of other risk fac-
tors30 and should be used in future studies addressing
stroke risk.
In the SIFAP1 study, most of the modiﬁable risk
factors, including current smoking, hypertension, dysli-
pidemia, diabetes, and excess alcohol drinking were
more prevalent among men, while physical inactivity
and high waist circumference were more prevalent in
women. In addition, there was a notable clustering of
these vascular risk factors with age in both sexes but
signiﬁcantly more pronounced in men (Figure 2).12
Outstandingly, only 7% of men aged 45–55 and 9%
of women of the same age group harbored none of
the traditional risk factors in the study. Similar ﬁndings
of risk factor clustering have been noted in other retro-
spective studies as well, with no diﬀerences in the risk
factor proﬁles across European regions.13
Strength of association of early onset
vascular risk factors
For stroke in the young, the strength of association of
risk factors is probably most solidly proven for smok-
ing. Several studies with participants from multiple eth-
nicities have shown the association for smoking and
early onset ischemic stroke, with odds ratios (OR) ran-
ging from 1.6 to 7.7.31–37 A cumulative dose eﬀect for
smoking has been demonstrated with no signiﬁcant het-
erogeneity between etiologic subtypes appeared.37
In contrast to smoking, surprisingly scarce data are
available regarding the strength of association of other
well-documented risk factors in young adults. For
hypertension, ORs have ranged from 1.6 to 8.9 in the
few case–control studies including young adults.31–36,38
Interestingly, in the INTERSTROKE study OR for
hypertension was 3.14 for ischemic stroke, but a sub-
stantial risk augmentation was observed for those 45
years (OR, 8.53), yet this estimate was for all stroke
including ischemic and hemorrhagic stroke.39
There is also other—yet limited and indirect—evi-
dence that the association of traditional vascular risk
factors may be stronger for younger individuals. For
instance, the INTERSTROKE OR for diabetes melli-
tus was 1.6, but in young adults the few studies have
suggested ORs ranging from 3.3 to 11.6, or even as high
as 22.9 for white men in the Baltimore–Washington
area.31,32,34,36 There is dearth of data regarding the dia-
betes subtypes in young adults with stroke, but it is
reasonable to suggest that the strength of association
would be stronger for type 1 juvenile diabetes mellitus
than for type 2 diabetes mellitus.40 Notably, a study
that followed patients with type 2 diabetes mellitus
found that the hazard of any macrovascular complica-
tion was twofold but the hazard stroke even 10-fold for
those with early onset form of type 2 diabetes compared
with patients with usual-onset type 2 diabetes despite
similar average time to require insulin in the groups.41
At least to some extent vascular comorbidities emerging
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at young age may thus represent earlier and more
aggressive forms of the diseases—i.e. ‘‘early onset
forms of older-onset risk factors,’’ leading to loss of
the relative protection of youth.41
Physical inactivity is among the most prevalent
modiﬁable risk factors in young stroke patients, but
its strength of association has remained nearly unstud-
ied. A study performed on a Thai population aged
18–45 years found that history of no or irregular exer-
cise increased stroke risk by eightfold after adjusting
for confounders. This OR was of similar magnitude
as for hypertension in that population.38 Physical
inactivity is linked to metabolic syndrome and its com-
ponents and so an Indian study found the presence of
three or more components of the metabolic syndrome
to be associated with early onset stroke.32
Regarding cholesterol and its components, an asso-
ciation between low high-density lipoprotein choles-
terol and ischemic stroke at young age has been
demonstrated,32,35,38 but no clear association has been
shown for total cholesterol, low-density lipoprotein
cholesterol, or triglycerides. A recent meta-analysis sug-
gests that the association of lipoprotein(a) and ischemic
stroke is stronger for young adults aged <55 years than
for older individuals.42
A few studies found rather modest association for a
composite variable of heart disease with varying deﬁn-
itions.33,34,36 Association of early onset atrial ﬁbrilla-
tion has not been assessed in young stroke patient
populations, although its prevalence might be under-
estimated.43 Regarding obstructive sleep apnea, one
study suggests higher stroke risk for women aged 35
years compared to older age groups and relatively
higher risk for women compared to men.44
The associations of long-term36 and recent heavy
drinking34,45,46 and ischemic stroke have been demon-
strated in young adults. The association of heavy drink-
ing may also be stronger for younger adults.47,48 One
study has also shown a protective eﬀect of mild-to-
moderate drinking in young women,49 which is in
accordance with the J-shape association found in non-
selected populations.48 Binge drinking pattern is more
common in young individuals,50 a risk factor for both
ischemic and hemorrhagic stroke particularly in young
adults.34,51
Are there risk factors specific for
young stroke?
While the risk factors discussed in the previous section
represent conditions with solid scientiﬁc evidence,39
there is a range of unconventional risk factors, of
which many may be considered speciﬁc to young
adults (Table 1). Young-age-speciﬁc risk factor may
only exist at young age, can exist at all ages but the
association appears stronger at younger ages, or the
factor can be related to hazardous behavior that is
more common at younger ages.
Generally, the evidence base underlying the associ-
ation of the risk factors presented in Table 1 is much
weaker than for the well-documented vascular risk fac-
tors; the results have often been inconsistent between
studies. Most of the original studies are small case–con-
trol studies prone to diﬀerent sources of bias. Meta-
analysis level of evidence is limited and virtually
restricted to most extensively studied conditions such
as migraine.54–56 Only very few of these risk factors
have shown dose dependency and time dependency,
which would be needed to increase the probability of
causal link between the risk factor and studied end-
point. It remains largely speculative, how much of
young stroke would be attributable to these risk
factors.
A notable common feature for the less well-docu-
mented risk factors is that most of them are frequent
in the background population. Therefore, it is plausible
to hypothesize that several concomitant factors may be
needed to cause the eﬀect, endpoint stroke. Examples of
such situations include antiphospholipid antibodies
needing an external trigger or concomitant factor
such as infection80 or estrogen use.59 Also for migraine
with aura, additional factors may be needed including
smoking and estrogen to aggravate the low independent
risk.81 PFO constitutes another similar condition with
uncertain risk alone, as discussed below.
The high burden of risk factors does not
translate into large proportion of defini-
tive stroke mechanisms in young adults
The single most frequent cause of young-onset ischemic
stroke in high-income countries is arterial dissection.82
Dissection together with other generally rare causes
considered the typical causes for young-onset stroke
explains only about one-fourth or one-ﬁfth of all
causes. These rare causes include, e.g. Fabry disease,
CADASIL (cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy),
MELAS (mitochondrial myopathy, encephalopathy,
lactic acidosis, and stroke), Moyamoya disease, revers-
ible cerebral vasoconstriction syndrome, systemic or
primary central nervous system vasculitis, cardiomyo-
pathies, HANAC syndrome (hereditary angiopathy
with nephropathy, aneurysms, and muscle cramps),
Sneddon’s syndrome, sickle-cell disease, and speciﬁc
coagulopathies.83 Full account of the rare conditions
is beyond the scope of this review.
Despite the recent studies showing a high prevalence
of traditional risk factors in young adults with ischemic
stroke, this fact does not translate into high frequency
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Table 1. Risk factors for ischemic stroke that may be considered specific to young adults.
Risk factor
Estimated prevalence
in patientsc Strength of associationa Comment
Pregnancy/puerperium52 7.5% in women RR 8.7 during puerperium No significant association found
for pregnancy; mixed results
Combined oral
contraceptives53
10–40% in women OR 2.1 for pills with 50 mg of
estrogen versus nonuse
Mixed results; no significant
association for any dose of
estrogen or lower than 50mg
dose of estrogen
Migraine54–56 20–27% OR 2.3 Stronger association found for
women, migraine with aura,
smokers, oral contraceptive
users, active migraine, and
cryptogenic stroke
Patent foramen ovale57 24–50% OR 5.1 for age <55 years No association found in popula-
tion-based studies58
Antiphospholipid
antibodiesb,59,60–65
18–46% Lupus anticoagulant: OR 2.2–
43.1 (women)
Mixed results; studied mostly in
women; stronger association
for smokers and oral contra-
ceptive users
Anticardiolipin antibodies: non-
significant to 1.78, depending
on isotype
Anti-b2-glycoprotein-I antibodies
(cut off 90th percentile of
control subjects): OR 2.3
(women)
Genetic
thrombophilia66–70
Prothrombin G20210A
mutation: 2–6%
OR 1.5 for prothrombin
G20210A mutation in cases
aged 55 years; stronger
association for cases 42
years
Often studied in selected popu-
lations; heterogeneous and
conflicting results between
individual studies
Factor V Leiden G1691A
mutation: 3.0–7.5%
Factor V Leiden G1691A
mutation: OR 1.4–2.7
depending on patient
selection
Protein C deficiency:
4–21%
Methylenetetrahydrofolate
reductase C677T: OR 1.2
Protein S deficiency:
6–23%
OR not reported for protein C,
protein S, and antithrombin III
deficiency
Antithrombin III defi-
ciency: 0.3–8%
Activated intrinsic coagu-
lation proteins71
&50% in women OR for all studied coagulation
proteins &2.5
Studied in young women (mean
age 39 years); increasing risk
with oral contraceptive use
Periodontitis72 Unknown OR 6.1 for >6mm attachment
loss
Significant association only for
patients <60 years; stronger
association for cryptogenic
stroke
Long work hours73 &9% RR 133 for working 55 h/week RR is for all stroke; dose–
response association found
Shift work74 Unknown RR 1.05
Psychological stress75 &29% OR 3.5
(continued)
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of patients classiﬁed as having typical older-onset causes
for their stroke.9,16,17 The SIFAP1 study is the largest
cohort to date of young stroke patients aged 18–55
with standardized diagnostic approach and brain MRI
in all patients, and 3396patientswith ischemic stroke and
1071 with transient ischemic attack (TIA) enrolled.16
According to Trial of Org 10172 in Acute Stroke
Treatment (TOAST) classiﬁcation,84 the frequency of
large-artery atherosclerosis in the SIFAP1 cohort was
18.6% and that of small-vessel disease 13.5%, with
higher frequencies inmen.Most patients with these diag-
noses fell in the oldest age group of 45–55 years, while
33.4% of the entire cohort had undetermined cause.
Notably, the proportion of cryptogenic strokes was
larger among younger age groups. Another study that
pooled data from 15 hospital-based registries of ischemic
stroke at age of 15–49 (n¼ 3331) also showed increasing
frequency of large-artery atherosclerosis and small-
vessel disease with age and higher prevalence of these
causes in men.17 In accordance with SIFAP1 study, the
frequency of cryptogenic strokes in that study was sub-
stantial and larger among the youngest age groups, being
up to 57% among those aged< 30 years if PFOs were
included in the count (Figure 3).17
Regardless of the large proportion of unknown
causes, recent ﬁndings, however, challenge the trad-
itional view about low prevalence of atherosclerosis in
young stroke patients. Another analysis based on the
SIFAP1 cohort showed overall prevalence of extracra-
nial stenoses of 8.9% and of intracranial stenoses of
11.8%. Together with nonstenotic plaques, one-ﬁfth
of the cohort had symptomatic or asymptomatic ath-
erosclerotic ﬁndings.14
How do the etiologic classification
schemes perform in young stroke?
An important issue that may artiﬁcially increase the
proportion of both young and old cryptogenic strokes
is the nature of classiﬁcation systems. The most widely
applied classiﬁcation, TOAST, was developed for more
than two decades age for the purposes of a clinical trial
and may be simply too robust and unspeciﬁc for young
patients. Furthermore, it has an overall rather modest
reliability between raters. A recent study on young
ischemic stroke patients85 utilized a new online classiﬁ-
cation system developed based on the old TOAST, the
Causative Classiﬁcation for Stroke, which uses certain
sophisticated rules to guide the rater and has greater
inter- and intra-rater reliability.86 Utilizing careful and
extensive diagnostic workup, that study85 suggested
that causal etiology could not be determined in only
11% of patients. However, a large proportion of cardi-
oembolic strokes had only isolated PFO, with no proof
of its causality.
The new ASCO (A for atherosclerosis, S for small-
vessel disease, C for cardiac source, O for other cause)
classiﬁcation characterizes patient phenotype in a more
comprehensive manner, considering relevant underlying
diseases and grades of evidence of the causative path-
ology as follows: grade 1, deﬁnitive cause; grade 2, caus-
ality uncertain; grade 3, unlikely a direct cause but the
disease is present. Nevertheless, attempts to classify
young patients with ASCO may lead to even larger pro-
portions of undetermined causes, as exempliﬁed by a
study by Larrue and colleagues where 52.7% of their
subcohort aged 16–44 years and 39.0% of those aged
Table 1. Continued
Risk factor
Estimated prevalence
in patientsc Strength of associationa Comment
Mean age of the study population
was 56 years
Air pollution76 NA OR 1.11 for particulate matter
<10mm
Case-crossover analysis; signifi-
cant association found for
individuals aged <55 years but
not for those 55 years
Heavy drinking34,36 12–59% OR 15.3 for long-term alcohol
consumption of 60 g/d
The association might be stron-
ger for younger adults47,48
Illicit drug use77–79 9–20% OR 2.3 for cannabis No independent association for
cannabis if adjusted for
smoking; no significant associ-
ation for amphetamine use
OR 2.0 for cocaine
OR: odds ratio; RR: relative risk.
aPooled estimate of the risk if meta-analysis level of data available.
bIn the absence of antiphospholipid antibody syndrome or systemic lupus erythematosus.
cVariability in the prevalence is primarily due to selection of cohorts and usually higher for cryptogenic cases.
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45–54 years had no deﬁnite cause (grade 1 pathology).87
Reclassiﬁcation of the SIFAP1 patient population led to
an even larger proportion of those without deﬁnitive
grade 1 cause, 70.7%. Absence of grade 1 or 2 pathology
was detected in 45.9%, but about 50% of patients in
that study had more than one ﬁnding with uncertain
causality and high prevalence of ﬁndings compatible
with concomitant atherosclerosis in the large arteries
or ﬁndings supportive of small-vessel disease.15
PFO—An example of a simple
structure with a complex role in the
chain of causality
Much of the uncertainty in classifying the potential
cause considers PFO, constituting a signiﬁcant propor-
tion of undetermined young-onset strokes. PFO can
serve as a conduit for paradoxical embolism originating
in deep vein thrombosis, but as simple as it appears in
case reports, PFO in fact exempliﬁes the entire com-
plexity of determining the potential pathogenetic mech-
anism for stroke in the absence of a deﬁnite cause. As
many other risk factor with uncertain causality, PFO is
common (&25%) in the general population,88 which
leads to high probability that PFO is just an innocent
bystander.89 Although case–control studies demon-
strate an association for PFO and stroke,57 no associ-
ation appears in strictly population-based studies.58
Proving the deﬁnite causality in clinical practice
remains a challenge as it requires that the venous
thrombosis be diagnosed prior to stroke, which is
rarely the case. It is therefore reasonable to argue
there must be other concomitant factors—persistent
or transient, recent or remote—predisposing to para-
doxical embolism in individuals with suggested
PFO-related stroke. These include transesophageal
echocardiography features—such as PFO length and
size, presence of atrial septal aneurysm, and right-to-
left shunt at rest90—as well as precipitants elevating the
risk for venous thrombosis (e.g. bed rest, long travel,
immobilization, trauma, lower extremity caster), infec-
tions, prothrombotic conditions,91 and recent physical
activity, particularly those inducing Valsalva maneuver.
Most studies have applied no criteria for adjudicating
PFO as causal or incidental, so the decision has merely
relied on the individual physician or investigator. A
recently developed Risk of Paradoxical Embolism
(RoPE) score may help to identify those PFOs that
would be causally relevant. The score, ranging from 0
to 10, is composed of age (0–5 points: 5 points if age
18–29 years, 0 point if age70 years), presence of cortical
infarct, and lack of traditional risk factors (one point for
each of the following: no hypertension, no diabetes, no
history of stroke or TIA, nonsmoker).92 It was further
evaluated whether the transesophageal echocardiog-
raphy characteristics were associated with the clinical
features assessed with the RoPE score suggesting that
PFO would be pathogenic—but no evidence of such
association was found.93 Therefore, additional measures
for determining the pathogenetic role of PFO are needed
and alternative causes to paradoxical embolism, such as
vulnerability to atrial arrhythmia94 and thrombosis
Figure 3. Distribution of etiologic subgroups in young adults with ischemic stroke according to TOAST classification in pooled data
from 15 hospital-based registries. Data adapted from Yesilot Barlas et al.17
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generation in PFO itself should be explored. In addition,
venous thrombosis in the pelvic veins or pulmonary
embolismmight be underestimated sources for embolism
as suggested by a few rather small prospective95 and
retrospective96,97 studies, albeit some of the results are
conﬂicting,98 warranting larger prospective
investigations.
The relationship of clustering risk factors
and dismal cardiovascular prognosis after
stroke in the young
Although it may seem favorable as compared to older
stroke patients, recent follow-up studies have chal-
lenged the traditional view, which considered the prog-
nosis of young adult stroke generally favorable. A
Dutch study showed a fourfold higher mortality for
young patients with stroke compared to age- and sex-
matched background population, with excess mortality
present across all age groups, but particularly for those
aged 35–50 years.99 In the most recent studies on long-
term mortality in young adult stroke, cumulative mor-
tality has ranged from 1.9 to 5.2% at one year, 9 to
11% at ﬁve years, 12 to 17% at 10 years, and 27% at 20
years, with the highest annual rate in the ﬁrst year.99–105
Importantly, more than half of the deaths in the long
term seem to occur due to vascular causes, of which
majority are other than strokes.99,101 Regardless of
stroke etiology and demographic factors, increasing
number of vascular risk factors has been shown to be
an independent marker of elevated risk of death in the
long term.106,107 Of the TOAST categories, large-artery
atherosclerosis carries the highest risk for death.106
Cumulative risk of recurrent stroke in young stroke
survivors is nonnegligible, ranging from 9.4% at ﬁve
years to 19.4% at 20 years in the largest of the recent
consecutive series.108,109 Composite of any vascular
event occurred at a rate of 11.5% at ﬁve years,108
30.4% at 10 years,100 and 32.8% at 20 years.109 As
for mortality, the risk for recurrent stroke and vascular
events is highest during the ﬁrst year but remains high
for years after the index event. Increasing number of
vascular risk factors independently predict as well
recurrent vascular events in these patients.106,109,110
Compared with undetermined causes and other deter-
mined rare causes, the highest risk for recurrent stroke
and vascular events emerge for large-artery atheroscler-
osis, cardioembolism, and small-vessel disease, yet
recurrences occur across all etiologic subgroups.108,109
Scarcity of evidence is guiding secondary
prevention
General guidelines are adopted for the treatment of
early onset strokes, despite young patients typically
are underrepresented in randomized trials and so the
results may not be directly translated to apply all
young patients. The virtually only randomized data for
secondary prevention that considers speciﬁcally younger
patients or causes that are common among young
patients come from the Patent Foramen Ovale in
Cryptogenic Stroke Study (PICSS),111 the Cervical
Artery Dissection in Stroke Study (CADISS),112 and
from the recently completed three trials comparing trans-
catheter closure of PFO with best medical treatment.113
PICSS was a subcohort to a larger study and showed no
diﬀerence in the risk of stroke or death in rather young
patients (mean age 59 years) between those treated with
aspirin orwarfarin. Therewas, however, a nonsigniﬁcant
trend in favor of warfarin in the subgroup of cryptogenic
strokes, yet of similar magnitude in patients with and
without PFO.111 CADISS study showed a very low rate
of recurrent strokes in patients aged 49 years with cer-
vical or vertebral artery dissection and so managed to
show no diﬀerence between aspirin and anticoagula-
tion.112 Finally, after none of the individual trials com-
paring transcatheter closure of PFO with best medical
treatment showed a treatment eﬀect favoring either one
of the treatments, a Cochrane meta-analysis of the three
trials concluded that closuremight in fact be harmful due
to increased risk of atrial ﬁbrillation. However, there
might be beneﬁt from the closure using a device with a
high rate of success in carefully selected patients, yet fur-
ther studies are warranted.113
Conclusions
The impact of early onset stroke is becoming more
important in the population due their increasing inci-
dence from 1980s to present, with young stroke causing
now almost half of the entire stroke burden globally.
One of the main reasons for the increase in incidence
may be that vascular risk factors have become more
prevalent in the population. Recent ﬁndings are thus
challenging the traditional view that classical risk fac-
tors would play a minor role in young stroke. As
opposite, vascular risk factors are highly prevalent
and in parallel with the clustering of vascular risk fac-
tors with distinct demographic patterns, mortality and
risks of recurrent stroke and other vascular events are
increased for years after the index stroke, exceeding the
corresponding risks in the background population.
Regarding stroke subtypes, the highest risk of recur-
rent events appears in subtypes considered typical for
older-onset stroke. There may be special features in the
vascular risk factors that manifest early in life and asso-
ciate with early onset stroke endpoint. As an important
practical implication, the identiﬁed high-risk patient
groups should be subjected to more close follow-up
and aggressive management of the underlying diseases.
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As more knowledge has been accumulating on the
traditional risk factors, a very large proportion of
young patients still remain without elusive patho-
physiology for their stroke. In such situations the
evidence base for secondary prevention is very thin
and the patients have to live in uncertainty for
years. These individuals also face increased risks of
death and recurrent vascular events suggesting
active underlying pathologies. A number of less
well-documented risk factors with generally weak
associations and poorly known role in the chain of
causality often are present in young patients with
ischemic stroke.
There are now strong incentives to initiate large pro-
spective collaborative studies to explore the speciﬁc fea-
tures and pathogenetic roles of both early onset forms
of known vascular risk factors and the less-well docu-
mented risk factors considered speciﬁc to young adults.
Furthermore, the utility of novel diagnostic modalities,
e.g. for cardiac and vessel-wall imaging should be inves-
tigated,114 as well as collect samples particularly for
studies of coagulopathies115 and genetics116 in order
to establish new risk factors and causal disease mech-
anisms leading to early onset strokes. All this should
eventually lead to developing next-generation pheno-
typing schemes that better ﬁt young individuals and
allow for personalized treatments and better care for
young stroke patients.
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